[Protective effects of heat shock protein 70 against hypoxic pulmonary hypertension in neonatal rats]

Le Wang1, Hai-Yan Wu, Ming-Xia Li

  • 1Department of Neonatology, First Affiliated Hospital of Xinjiang Medical University, Ürümqi 830054, China. 2583051008@qq.com.

Insights

Heat shock protein 70 (HSP70) protects against hypoxic pulmonary hypertension (HPH) in neonatal rats. HSP70 therapy reduced pulmonary artery pressure and vascular remodeling, offering a potential new treatment for HPH.

Area of Science:

  • Cardiovascular Research
  • Neonatal Medicine
  • Molecular Biology

Background:

  • Hypoxic pulmonary hypertension (HPH) poses a significant threat to neonates.
  • Understanding the molecular mechanisms underlying HPH is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the protective effects of heat shock protein 70 (HSP70) against HPH in a neonatal rat model.
  • To evaluate HSP70's impact on pulmonary artery pressure and vascular remodeling.

Main Methods:

  • Neonatal rats were divided into control, HPH model, empty virus, and HSP70-treated groups.
  • HPH was induced, and interventions (saline, Ad-GFP, or Ad-HSP70) were administered.
  • Pulmonary artery pressure, vascular structure, and protein expression (HSP70, HIF-1α, ET-1, iNOS) were assessed.

Main Results:

  • HSP70 treatment significantly reduced mean pulmonary arterial pressure (mPAP) compared to HPH model and empty virus groups.
  • HSP70 administration alleviated pulmonary vascular remodeling (MA% and MT%).
  • HSP70 group showed increased HSP70 expression and decreased expression of HIF-1α, ET-1, and iNOS.

Conclusions:

  • HSP70 transfection effectively increases HSP70 expression in lung tissue.
  • HSP70 downregulates HIF-1α, ET-1, and iNOS, mitigating pulmonary vascular remodeling and reducing pulmonary artery pressure.
  • HSP70 represents a promising therapeutic strategy for neonatal HPH.
Abstract

Related Concept Videos